about
Explaining the geographical variation of HIV among injection drug users in the United StatesNaloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: a pilot intervention studyReinterpreting ethnic patterns among white and African American men who inject heroin: a social science of medicine approachIntertwined epidemics: national demographic trends in hospitalizations for heroin- and opioid-related overdoses, 1993-2009A SBIRT curriculum for medical residents: development of a performance feedback tool to build learner confidence.Urban segregation and the US heroin market: a quantitative model of anthropological hypotheses from an inner-city drug market.Stimulant abuse: pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapyThe entry of Colombian-sourced heroin into the US market: the relationship between competition, price, and purity.Heroin-related overdose: The unexplored influences of markets, marketing and source-types in the United StatesInjecting drugs in tight spaces: HIV, cocaine and collinearity in the Downtown Eastside, Vancouver, Canada.Nationwide increase in hospitalizations for heroin-related soft tissue infections: Associations with structural market conditions.Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose: a survey of street-recruited injectors in the San Francisco Bay AreaReframing "prevention with positives": incorporating counseling techniques that improve the health of HIV-positive patients.Nationwide increase in the number of hospitalizations for illicit injection drug use-related infective endocarditisIntegrating HIV risk reduction into the medical curriculumThe good-enough science-and-politics of anthropological collaboration with evidence-based clinical research: Four ethnographic case studiesImpact of South American heroin on the US heroin market 1993-2004Fire in the vein: Heroin acidity and its proximal effect on users' health."Every 'never' I ever said came true": transitions from opioid pills to heroin injecting.Heroin uncertainties: Exploring users' perceptions of fentanyl-adulterated and -substituted 'heroin'.The Textures of Heroin: User Perspectives on "Black Tar" and Powder Heroin in Two U.S. Cities.The relationship between US heroin market dynamics and heroin-related overdose, 1992-2008.US regional and demographic differences in prescription opioid and heroin-related overdose hospitalizations.Saying goodbye to high-dead-space syringes.Henceforth harm reduction?Risk factors for skin and soft-tissue abscesses among injection drug users: a case-control study.Fentanyl in the US heroin supply: A rapidly changing risk environment.A technology-enhanced medical note-writing workshop.Sold as Heroin: Perceptions and Use of an Evolving Drug in Baltimore, MD.'Care and Prevent': rationale for investigating skin and soft tissue infections and AA amyloidosis among people who inject drugs in London.Toots, tastes and tester shots: user accounts of drug sampling methods for gauging heroin potency.Drawing attention to a neglected injecting-related harm: a systematic review of AA amyloidosis among people who inject drugsFentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the Southeastern United StatesIllicit fentanyls in the opioid street market: desired or imposed?The triple wave epidemic: Supply and demand drivers of the US opioid overdose crisisHeroin Smoking Is Not Common in the United StatesHeroin type, injecting behavior, and HIV transmission. A simulation model of HIV incidence and prevalenceFentanyl: the many challenges aheadUndiagnosed HIV infection in acute care hospitals
P50
Q24537299-6191C7CE-4631-4C5E-9B88-885DE1A7053AQ24650146-035F637F-4114-41B4-9EC6-31408E0B5240Q28469064-5B48E623-A22E-4AD6-9076-5365D2B7098AQ28486015-3A66950F-044C-440B-BBB2-112BD05114E0Q30418594-B0F0CCFA-21F3-40EF-AD64-7D1BAD0F9B52Q33774305-678097F0-8BD6-4194-BD0B-A7E0991F813CQ34167229-DEFB5C6B-D4F3-433F-93FF-9D52F020F69FQ35037760-87E6D357-108E-421B-A09D-A78F15443046Q35707238-4E8A638A-E6C6-489E-9BB3-F22DC1E259F1Q35999959-C8F257BA-A043-4399-8331-5B3086D9AFE4Q36011523-331DC75F-07A8-41C6-9DA0-3C578D8B4289Q36273617-A05AF708-F43B-462A-98C7-154F82581141Q36373515-B3D74686-BB0C-461A-AE35-B1960771CB25Q36938224-0F765848-98D2-40BE-AABA-1E8B971FDFA6Q36963876-11A97575-9AD4-4095-84ED-7BF8CEC6A22FQ37179489-FE963323-CA57-4B85-85CD-0360184DFDDEQ37285892-D75AFBF3-BA9E-4BE1-B360-6ED82A81EE98Q37495070-6AFFF9CC-792D-4514-82CA-2DCBA06B3AD8Q37652892-4EC268A1-2411-460B-B0A5-C55261056362Q38429650-E7D42D6E-4DF3-4743-9953-82986ED312D5Q38437019-5D56429E-0A44-4E7D-B6CE-C60C0131DEC1Q38448845-BC104920-B030-4B2F-80CA-DC12F85D4D1EQ38688434-3558AD87-3B5F-4A62-BFC9-887113C40B6AQ42287673-35C99DAB-C7C4-42CD-8E04-309F59A81113Q43117337-DC038E67-8DE4-4FCD-965D-EADE3F2E8F46Q43628080-D84EF2B0-EBB3-4028-969D-4A12457D4D4BQ44257014-21D88AB3-8EC9-4450-9A97-31521954E4B6Q44300387-95996A9E-31D9-4E93-9EF2-B4F102E000E3Q46347389-70B7E09D-DAEC-4E2F-BAB9-597AE34948FEQ54217916-E1E0734A-C05C-4B6B-B992-CF167D310113Q54987498-CEB5FFF6-CFDD-43C9-8BB7-ADE9F61AF9F3Q56886717-68BBDA46-6180-43C2-9B9F-845DDCBFEC47Q57190985-9E268BD9-AFE2-4C6A-92C6-FF0F2FB9CE87Q59649772-16955CF6-BA8A-43CE-8D85-18F82A5A0F98Q91339015-383D7189-A74B-4C48-AAD6-F9B17B06C7D5Q92266083-6DCE0AAF-B25B-432E-B7D0-1D04856FDAE8Q92320587-0E9F48C3-B8B2-4C2E-ACA4-E9794AFBDFDBQ92379033-DCF5AB37-7642-4EE9-9184-979705FF0B39Q95818578-FF0595EF-E337-4D2E-A93C-30D7D5AA0034
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Dan Ciccarone
@ast
Dan Ciccarone
@en
Dan Ciccarone
@es
Dan Ciccarone
@nl
Dan Ciccarone
@sl
type
label
Dan Ciccarone
@ast
Dan Ciccarone
@en
Dan Ciccarone
@es
Dan Ciccarone
@nl
Dan Ciccarone
@sl
prefLabel
Dan Ciccarone
@ast
Dan Ciccarone
@en
Dan Ciccarone
@es
Dan Ciccarone
@nl
Dan Ciccarone
@sl
P1053
B-3322-2016
I-5404-2013
P106
P1153
6602102963
P21
P31
P3829
P3835
dan-ciccarone
P496
0000-0002-2355-5477